Precision Biologics
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4922 Fairmont Ave Ste 320, Bethesda, Mar...Phone Number
(301) 500-8646Website
www.precision-biologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Precision Biologics
Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Precision Biologics is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way the company detect and treat cancer.Explore more
Precision Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Precision Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Precision Biologics has new funding data
Precision Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Precision Biologics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Precision Biologics
Check if Precision Biologics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Precision Biologics launches new products
Earning: See what the market has to say on Precision Biologics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Precision Biologics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Precision Biologics as Masked Content
Find more new buyers
Compare Similar Companies to Precision Biologics
Compare insights from companies similar to Precision Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Precision Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Precision Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Precision Biologics.
Precision Biologics financials insights
Gather financial insights about Precision Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$5.3M
2013
Multiple Rounds
$14.6M
2015
Private Equity
$53.1M
2020
Debt
$150K
Precision Biologics Tech Stack
A closer look at the technologies used by Precision Biologics
See more technologies
Most Recent Scoops
Project
Product Management, Intellectual Property, Legal Affairs, Clinical Operations
Project
Product Development, Intellectual Property, Legal Affairs
Funding
Precision Biologics has received an SBA PPP loan for $150,000-350,000 from Capital One, supporting the retention of 4 jobs.
Funding
Precision Biologics News & Media
Precision Biologics' development of monoclonal antibodies against tumor-specific targets in cancer to be focus of presentation at the Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026
BETHESDA, Md., March 2, 2026 /PRNewswire/ -- Precision Biologics, Inc. CEO Philip M. Arlen, MD, discusses discovery and development of tumor-specific monoclonal antibodies (mAb) in "Discovery and Development of Monoclonal Antibodies Targeting Tumor Specific Neoepitopes" at the Festival of...Precision Biologics' New PB-223 ADC Targeting Multiple Cancer Types to Be Highlighted in Keynote at 6th ACE Drug Discovery Summit
London, UK - February 19, 2026 BETHESDA, Md., Feb. 13, 2026 /PRNewswire/ -- Precision Biologics, Inc. CEO Philip M. Arlen, MD gives a Keynote presentation describing in vitro and in vivo efficacy of its novel tumor-specific antibody-drug-conjugate PB-223 ADC (PB-vcMMAE-5). Recent tumor...Precision Biologics to Reveal Preclinical Efficacy of Novel Tumor-Specific ADC against multiple human cancer types at SITC 2025
BETHESDA, Md., Nov. 5, 2025 /PRNewswire/ -- Precision Biologics, Inc. announces in vitro and in vivo efficacy of its novel tumor-specific ADC (PB-vcMMAE-5) against human carcinomas expressing truncated core 2 O-glycans. Recent data for several human cancer types expressing truncated core...Precision Biologics to Unveil In Vitro and In Vivo Efficacy of New ADC against human ovarian cancer at AACR Special Conference
BETHESDA, Md., Sept. 19, 2025 /PRNewswire/ -- Precision Biologics, Inc. reports that in vitro and in vivo efficacy of the novel ADC, using its anti-core 2 O-glycans anti-human carcinoma mAb PB-223 (PB-vcMMAE-5), against human ovarian cancer expressing truncated core 2 O-glycans will be...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Precision Biologics
Sign Up For FreeTo access detailed company insights
Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor... Read More
